Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The development of suitable three-dimensional matrices for the maintenance of cellular viability and differentiation is critical for applications in tissue engineering and cell biology. To this end, gel matrices of different proportions of alginate/elastin/polyethylene glycol (Alg/
Ela
/PEG) were prepared and examined. The composite matrix membranes were evaluated for their porous scaffold using
SEM
, enzymatic degradation and water content. An equal blend of Alg/
Ela
with a ratio of Alg/
Ela
: PEG (7:3) was selected for fabricating Alg/
Ela
/PEG scaffolds for this study. The Alg/
Ela
/PEG membranes fabricated at 20 degrees C and - 20 degrees C had a mean surface pore size of 35-45 microm. However, their ultrastructures had shown bigger pore structures (60-75 microm) compared to their surface. It is interesting to note that the membranes of Alg/
Ela
/PEG prepared at 20 degrees C had larger ultrastructural pores than that of membranes prepared at -20 degrees C. Further, the
SEM
studies revealed that in the absence of PEG the composite membranes of Alg/
Ela
formed with less porous structures. The water content of membranes prepared at 20 degrees C was higher with Alg/
Ela
/PEG (61.6 +/- 4.8%), compared to Alg/
Ela
(49.9 +/- 0.3%). The enzymatic degradation and water content studies also revealed that the membranes fabricated at - 20 degrees C had high water uptake and low enzymatic degradation, as that of the membranes prepared at 20 degreees C. In other words the larger pore structured membranes had less water content and high degradation profile. This study proposes that this novel composite matrix produces a hierarchical structure that is useful for generating tissue scaffolds for repairing the failing cardiac muscles. However, more detailed investigations with cytocompatibility studies are needed to find applications.
...
PMID:The development of porous alginate/elastin/PEG composite matrix for cardiovascular engineering. 1279 21